The clinical characteristics and prognosis of patients with SAPHO syndrome--a real-world cohort study

被引:1
|
作者
Duan, Hongji [1 ]
Gao, Shuang [2 ]
Zhang, Lihua [3 ]
Song, Le [4 ]
Zhai, Jiayu [5 ]
Deng, Xiaoli [1 ]
机构
[1] Capital Med Univ, Beijing Jishuitan Hosp, Dept Orthoped Med, 31 Xinjiekou East St, Beijing 100035, Peoples R China
[2] Peking Univ Third Hosp, Lymphoma Ctr, Dept Hematol, Beijing, Peoples R China
[3] Peking Univ Third Hosp, Dept Radiol, Beijing, Peoples R China
[4] Peking Univ Third Hosp, Dept Nucl Med, Beijing, Peoples R China
[5] Peking Univ Third Hosp, Dept Rheumatol & Immunol, Beijing, Peoples R China
关键词
Iguratimod; Outcome; SAPHO syndrome; Treatment; NF-KAPPA-B; OSTEITIS SAPHO; SINGLE-CENTER; HYPEROSTOSIS; PUSTULOSIS; ACNE; SYNOVITIS; CELLS; T-614; BONE;
D O I
10.1007/s10067-023-06782-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectivesWe aimed to analyze the clinical characteristics and outcomes of patients with synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome.MethodsThe clinical records of 64 patients with SAPHO syndrome were collected, and the treatment and outcomes of 27 patients were followed up. The patients were divided into three groups according to the site of bone lesions: only anterior chest wall (ACW) involvement, only spinal involvement, and bone lesion involvement at both sites. The clinical characteristics and outcomes were compared. The clinical characteristics of the patients with and without peripheral joint involvement were compared.ResultsAmong all patients, 31.25% (20/64) had only ACW involvement, 15.63% (10/64) had only spinal involvement, and 53.12% (34/64) had both ACW and spinal involvement. Peripheral joint involvement was observed in 25.00% (16/64) of the patients. Patients with only spinal involvement were older than those with only ACW involvement (p = 0.006). Patients with both ACW and spinal involvement were older than those with only ACW involvement (p = 0.002) and had a longer diagnosis delay (p = 0.015). Patients with peripheral joint involvement were younger than those without peripheral joint involvement (p = 0.028). During follow-up, 88.89% (24/27) of patients had good outcomes. Twenty-two patients were treated with non-steroidal anti-inflammatory drugs + Iguratimod (IGU), and the outcomes of 90.91% (20/22) improved.ConclusionsA relationship may exist between the sites of bone lesions and clinical characteristics of patients with SAPHO syndrome. The clinical outcomes of these patients may be good, and IGU may be effective in treating SAPHO syndrome.Key Points center dot This study is the first long-term follow-up on the effectiveness of iguratimod in treating patients with SAPHO.center dot This study revealed that patients with SAPHO and different bone lesion sites may present with different clinical characteristics.
引用
收藏
页码:561 / 568
页数:8
相关论文
共 50 条
  • [41] Real-World Clinical and Laboratory Characteristics in Severe Hemophilia a Patients Commencing Emicizumab
    Ling, Gavin
    Ajidahun, Aderonke
    Austin, Steve K.
    Dolan, Gerard
    McCormick, Aine
    BLOOD, 2020, 136
  • [42] Real-World Characteristics, Treatment Utilization, and Transfusion Burden in Patients with β-Thalassemia Initiating Luspatercept: A US Cohort Study
    Sheth, Sujit
    Glassberg, Mrudula B.
    Lee, Jana
    Ip, Queeny
    Liu, Jingyuan
    Bueno, Luciana Moro
    BLOOD, 2023, 142
  • [43] PATIENT CHARACTERISTICS AND TREATMENT PATTERNS IN PATIENTS WITH MANTLE CELL LYMPHOMA IN CHINA: A REAL-WORLD, CONTEMPORARY COHORT STUDY
    Liu, Y.
    Bao, Y.
    Chen, Y.
    Zhou, J.
    VALUE IN HEALTH, 2024, 27 (06) : S162 - S162
  • [44] Clinical outcomes of high-intensity doses of atorvastatin in patients with acute coronary syndrome: A retrospective cohort study using real-world data
    Rahhal, Alaa
    Khir, Fadi
    Aljundi, Amer Hussien
    AlAhmad, Yaser
    Alzaeem, Hakam
    Habra, Masa
    Al-Shekh, Israa
    Mahfouz, Ahmed
    Awaisu, Ahmed
    Al-Yafei, Sumaya
    Arabi, Abdul Rahman
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (04) : 2043 - 2052
  • [45] Mortality risk factors in primary Sjogren syndrome: a real-world, retrospective, cohort study
    Brito-Zeron, Pilar
    Flores-Chavez, Alejandra
    Horvath, Ildiko Fanny
    Rasmussen, Astrid
    Li, Xiaomei
    Olsson, Peter
    Vissink, Arjan
    Priori, Roberta
    Armagan, Berkan
    Hernandez-Molina, Gabriela
    Praprotnik, Sonja
    Quartuccio, Luca
    Inanc, Nevsun
    oezkiziltas, Burcuguel
    Bartoloni, Elena
    Sebastian, Agata
    Romao, Vasco C.
    Solans, Roser
    Pasoto, Sandra G.
    Rischmueller, Maureen
    Galisteo, Carlos
    Suzuki, Yasunori
    Trevisani, Virginia Fernandes Moca
    Fugmann, Cecilia
    Gonzalez-Garcia, Andres
    Carubbi, Francesco
    Jurcut, Ciprian
    Shimizu, Toshimasa
    Retamozo, Soledad
    Atzeni, Fabiola
    Hofauer, Benedikt
    Melchor-Diaz, Sheila
    Gheita, Tamer
    Lopez-Dupla, Miguel
    Fonseca-Aizpuru, Eva
    Giacomelli, Roberto
    Vazquez, Marcos
    Consani, Sandra
    Akasbi, Miriam
    Nakamura, Hideki
    Szanto, Antonia
    Farris, A. Darise
    Wang, Li
    Mandl, Thomas
    Gattamelata, Angelica
    Kilic, Levent
    Pirkmajer, Katja Perdan
    Abacar, Kerem
    Tufan, Abdurrahman
    de Vita, Salvatore
    ECLINICALMEDICINE, 2023, 61
  • [46] Real-world outcomes for patients with pleural mesothelioma: A multisite retrospective cohort study
    Chow, Kar Ven Cavan K. V. C. C.
    Turner, CassieC. T.
    Hughes, BrettB. H.
    Houston, Kathleen K. H.
    Lwin, Zarnie Z. L.
    Chan, Bryan B. C.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 159 - 159
  • [47] Clinical characteristics and outcomes of patients with advanced hepatocellular carcinoma treated with immunotherapy: A real-world retrospective study
    Chergui, Adel
    Gadde, Eswar
    Tolu, Seda Serra
    Acuna-Villaorduna, Ana
    Kabarriti, Rafi
    Goel, Sanjay
    Kaubisch, Andreas
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [48] Distinguishing laboratory characteristics in giant cell arteritis: a real-world retrospective cohort study
    Goel, Raghav
    Usmani, Eiman
    Bacchi, Stephen
    Simon, Sumu
    Chan, Weng Onn
    INTERNATIONAL OPHTHALMOLOGY, 2023, 43 (11) : 4197 - 4201
  • [49] Distinguishing laboratory characteristics in giant cell arteritis: a real-world retrospective cohort study
    Raghav Goel
    Eiman Usmani
    Stephen Bacchi
    Sumu Simon
    Weng Onn Chan
    International Ophthalmology, 2023, 43 : 4197 - 4201
  • [50] Real-world benefit of iloprost in patients with critical limb ischemia: A cohort study
    Dari, L.
    Constans, J.
    Boulon, C.
    Caradu, C.
    Labepie, F. X.
    Bura-Riviere, A.
    Chastaingt, L.
    Lacroix, P.
    Bezin, J.
    Pariente, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 164 - 165